HIGHLIGHTS
- who: Xiaoliang Li and colleagues from the Centre, Australia Chongqing University of Technology have published the research: Platelet-promoting drug delivery efficiency for inhibition of tumor growth, metastasis, and recurrence, in the Journal: (JOURNAL)
- future: Artificial platelets released from human-induced pluripotent stem_cell-derived MKs could be a sufficient resource for clinical applications in the near future and the authors could also expect that with the help of gene editing and chemical editing the membrane protein expression level on the artificial platelets would be precisely regulated to let the Frontiers in Oncology
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.